BSE filing, NSE: DOLPHMED. Summary written from the filing by ALFA Finder's alert engine.
Dolphin Medical Services Ltd: key numbers
- Share price
- ₹6.78
- Market cap
- ₹10.24 Cr
- Revenue (annual)
- ₹0.75 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- 214.6×Sector 52.8×
- Promoter holding
- 100.00%+73.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dolphin Medical Services Ltd
All →Dolphin Medical Services Other Announcement
Dolphin Medical Services Ltd filed its quarterly shareholding pattern as mandated by SEBI Regulation 31(1)(b). This document provides no material business event.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services scheduled a board meeting for September 21, 2026. The agenda includes board appointments, committee reconstitution, and promoter reclassification.
Dolphin Medical Services Board Meeting Outcome
Dolphin Medical Services Limited announced the immediate resignation of its Managing Director and CEO, Mr. G V Mohan Prasad, and two other directors.
Dolphin Medical Services Annual General Meeting
Dolphin Medical Services Ltd received Registrar of Companies approval to extend its Annual General Meeting deadline by two months. The meeting is now scheduled for November 30, 2026.
- Execution
- 2 months extension
Dolphin Medical Services Open Offer: ₹0.01 Cr
Acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar completed an open offer for Dolphin Medical Services Limited. They acquired 18,000 shares at ₹4.80 each, totaling ₹0.01 Crore.
- Value
- ₹0.01 Cr
Dolphin Medical Services Q1 FY27 Results: Net Profit ₹0 Cr
Dolphin Medical Services Ltd reported revenue from operations of ₹0.2 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other management change announcements
All →NHPC Management Change
NHPC disclosed that Executive Director Shri Vivek Dwivedi's tenure ends on superannuation, effective October 31, 2026. The filing reports no replacement or financial impact.
BEML Management Change
BEML Limited informed exchanges that two senior executives, including the Executive Director (Offg.) Aparup Sinha, ceased office on superannuation effective 31 October 2026. No monetary value is involved.
Jay Jalaram Technologies Management Change
Jay Jalaram Technologies appointed Varjivandas Nathuram Thakkar as Non-Executive Non-Independent Director and Vishnu Harjivanbhai Thaker as Company Secretary. Both appointments are effective 31 October 2026.
Chennai Petroleum Corporation Management Change
Chennai Petroleum's Director (Operations) P. Kannan ceased on superannuation, effective 31 October 2026. S. G. Venkatesh takes additional charge from 1 November 2026.
GAMCO Management Change
GAMCO appointed Jayshri Tulsyan as Non-Executive Independent Director for 24 months, effective October 31, 2026. Ayushi Khaitan resigned as Non-Executive Non-Independent Director, citing personal reasons.
Dhampur Bio Organics Management Change
Dhampur Bio Organics' VP Financial Planning and Analysis, Harmeet Singh, resigned, effective October 31, 2026. It is a senior management departure.